CMS announced a $3.4 billion medical equipment supplier fraud scheme involving 11 suppliers and claims for deceased beneficiaries. Here is what it means….by Reginald Hislop III
On September 8, 2026, CMS announced that it had moved against a medical equipment supplier fraud scheme valued at $3.4 billion (CMS Cracks Down on Massive $3.4 Billion Medical Equipment Supplier Fraud Scheme | CMS). The announcement identifies 11 suppliers, ties the scheme to claims billed to Medicare for deceased beneficiaries, and describes coordination with HHS OIG. It also leans on a tool that gets far less attention than it deserves: the Preclusion List. For providers, plans, and anyone billing Medicare for durable medical equipment, the mechanics of this case matter more than the headline number, because the mechanics are the part that repeats.
What CMS Announced
The CMS press release, titled “CMS Cracks Down on Massive $3.4 Billion Medical Equipment Supplier Fraud Scheme,” centers on 11 suppliers. The subtitle of the announcement states plainly that companies billed Medicare for deceased beneficiaries. CMS coordinated with HHS OIG in developing the action.
The dollar figure, $3.4 billion, refers to the value of the fraudulent scheme, not to what Medicare necessarily paid out. That distinction is standard in fraud enforcement and worth keeping straight when the number gets repeated in trade coverage. It also tells you something about scale. Schemes of this size are rarely the work of one storefront. They depend on volume, on enrollments, and on a billing infrastructure that can push claims fast enough to stay ahead of detection.
CMS framed the response around enforcement levers it controls directly. Two are worth naming:
- Supplier enrollment and revocation authority, used to cut off Medicare billing privileges
- The Preclusion List, used to prevent certain providers and suppliers from being paid by Medicare
Both sit inside the agency’s administrative toolkit. Neither requires a criminal conviction to take effect. That is the design intent, and it is the reason CMS can act on a scheme of this size without waiting on a courtroom.
Billing for Deceased Beneficiaries
The specific allegation in this case is not subtle. Claims were submitted for people who were no longer alive. That is a data problem before it is a fraud problem, and it reveals how the scheme operated. If a supplier holds a valid Medicare number, the claim can be built, transmitted, and paid through automated adjudication. Nothing in the standard claims flow requires the supplier to have actually seen the patient. This schema has been problematic for years.
Deceased beneficiary billing is one of the more detectable versions of Medicare medical equipment fraud. CMS and its contractors maintain death records, and cross-matching a claim against those records is a routine edit. The fact that claims still cleared tells you the scheme relied on a window of time, on volume, or on gaps in enrollment screening that let the suppliers establish billing privileges in the first place.
HHS OIG has documented the broader pattern behind this kind of activity. In its DME fraud work, the agency describes bad actors billing for equipment that is never delivered, providing items that are not needed, and substituting billed items for something else. Deceased beneficiary billing is a variant of the first category. The equipment does not exist because the person it was ordered for does not exist either.
The Preclusion List and Supplier Removal
The Preclusion List is the mechanism CMS uses to stop payment to providers and suppliers it has determined should not participate in Medicare. Once a supplier lands on the list, Medicare Advantage plans and Part D sponsors are expected to reject claims from that entity. In effect, the list pushes part of the enforcement burden downstream to the plans.
That has a practical consequence for Medicare Advantage organizations. A plan that pays a precluded supplier creates its own exposure. CMS has been explicit that plans bear responsibility for checking the list, and the compliance function around that check is not optional. When CMS acts against 11 suppliers at once, the downstream claims activity does not disappear. It reappears in plan-level data, sometimes under a different tax identification number or a related entity.
Operators in post-acute care interact with this world more than they may realize. Facilities that order equipment for residents, that accept equipment deliveries, and that document medical necessity sit inside the supply chain that fraudsters exploit. A supplier looking for Medicare numbers does not care whether the facility knows what it is doing. It only needs cooperation or inattention.
What OIG Says About DME Fraud Patterns
HHS OIG has published extensively on durable medical equipment fraud. Across its reports and educational material, three recurring exploitation areas appear:
- Fake orders, where documentation is fabricated to support a device that was never legitimately prescribed
- Stolen identifiers, where beneficiary Medicare numbers are obtained and used without the person’s knowledge
- Compromised suppliers, where legitimate enrollment status is used as cover for illegitimate billing
OIG has also flagged a beneficiary-side pattern. In some cases a beneficiary knowingly accepts money, gifts, or unnecessary equipment and supplies from a supplier in exchange for their Medicare number. That version is harder to detect because the beneficiary may not report it and may not view it as participation in fraud. It also complicates recovery efforts.
The common thread across all these patterns is the medical necessity requirement. Medicare requires that a device be medically reasonable and necessary for the diagnosis or treatment of a condition. Fraudsters work around that requirement rather than satisfy it. They generate orders without a legitimate clinical basis, they bill for items nobody prescribed, and they target beneficiary populations less likely to question a package arriving at the door.
DME is a frequent target precisely because the category is broad and the billing is repetitive. Wheelchairs, oxygen tanks, and glucose monitors are among the devices OIG cites as examples. Supplies attached to those devices generate recurring claims, and recurring claims generate volume. Volume is where fraud lives.
A Recent Prosecution Shows the Same Pattern
Administrative action is only one side of this. The Department of Justice has continued to prosecute durable medical equipment cases, and the numbers in those cases track the same mechanics. In a Justice Department announcement dated March 9, 2026, the owner of a durable medical equipment company, Cassells, was sentenced in connection with a case involving more than $59.9 million in false and fraudulent claims to Medicare, of which Medicare paid more than $27 million.
The gap between the two figures is instructive. Billed amounts and paid amounts are not the same, and any analysis of a fraud scheme that treats them as interchangeable overstates the loss. The $3.4 billion figure in the CMS announcement should be read with the same caution.
What This Means for Providers and Health Plans
The enforcement posture here is not temporary. CMS has the authority to revoke enrollment and to preclude suppliers administratively, and it exercised that authority across 11 entities at once. Expect the screening around new supplier enrollments to tighten, and expect more attention on claims that touch deceased beneficiary records.
For skilled nursing and senior living providers, the implications are operational:
- Know which suppliers are serving your residents and verify their Medicare enrollment status. Providers can establish preferential relationships with suppliers and even exclusive for services such as hospice.
- Do not allow suppliers to collect Medicare numbers from residents or families on your premises without a documented clinical purpose.
- Keep records that support why a device was ordered, who ordered it, and that it was delivered.
- Treat unexplained equipment deliveries as a reportable event internally, not an administrative annoyance.
For Medicare Advantage plans and other payers, the Preclusion List check is the obvious control, but it is not sufficient on its own. Claims from a precluded entity can reappear through affiliated billing arrangements. Monitoring supplier-level billing patterns, watching for spikes tied to a narrow set of procedure codes, and reconciling against death records are the practical defenses.
The larger point is that this scheme was built on the assumption that nobody was looking at the relationship between the beneficiary and the claim. That assumption has been tested repeatedly, and it keeps failing eventually. The question for providers and plans is whether it fails on CMS’s timeline or on theirs.
Reporting Suspected Medicare Medical Equipment Fraud
If you suspect fraud, CMS directs callers to 1-800-MEDICARE (1-800-633-4227) or to the online Medicare fraud reporting tool. Beneficiaries enrolled in a Medicare Advantage Plan or a Medicare drug plan can also report concerns through that plan. Providers who identify suspicious supplier activity around their residents should document what they observed, including dates, supplier names, and the equipment involved, before filing a report.
Fraud reporting works best when it is specific. A report that a supplier “seems off” is difficult to act on. A report that identifies a beneficiary, a date of service, an item, and the absence of any clinical order gives investigators something to pursue. As the CMS announcement shows, the agency is willing to act at scale when the pattern is documented.
Frequently Asked Questions
What did CMS announce about the $3.4 billion medical equipment fraud scheme?
CMS announced action against 11 medical equipment suppliers in connection with a scheme valued at $3.4 billion. The announcement states that companies billed Medicare for deceased beneficiaries, and that CMS coordinated with HHS OIG. The action relies on CMS administrative authority, including supplier enrollment controls and the Preclusion List, rather than a criminal conviction.
How do suppliers bill Medicare for deceased beneficiaries?
A supplier holding a valid Medicare number can submit a claim that adjudicates through automated systems without proving the patient was seen. Death records exist, and cross-matching is a routine edit, so these claims survive only through volume, timing, or gaps in enrollment screening. OIG separately cites fake orders, stolen identifiers, and compromised suppliers as recurring exploitation methods.
What is the CMS Preclusion List?
The Preclusion List identifies providers and suppliers that Medicare will not pay. Medicare Advantage plans and Part D sponsors are expected to reject claims from entities on the list, which shifts part of the enforcement burden downstream. A plan that pays a precluded supplier creates its own compliance exposure, since checking the list is a plan responsibility.
